The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...

Jul 17, 2024 · Insomnia is common and frequently occurs with other disorders. First-line cognitive behavioral therapy with or without medication can produce rapid, sustained alleviation of insomnia symptoms.

Mar 21, 2023 · New perspectives on community-acquired pneumonia in 388 406 patients: results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009;64:1062-1069. Crossref

Feb 7, 2024 · From the University of Oxford, Oxford (S.A.H.), the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne (Q.M.A.), and the National ...

Sep 24, 2020 · Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diab...

Sep 14, 2022 · A total of 249 patients were included in the interim analysis. The trial was halted owing to between-group differences in the safety outcomes without a significant difference in the incidence of ...

Nov 6, 2022 · Despite advances in defibrillation technology, shock-refractory ventricular fibrillation remains common during out-of-hospital cardiac arrest. Double sequential external defibrillation (DSED; rapid...

Dec 31, 2024 · On November 4, 2024, a 13-year-old girl with a history of mild asthma and an elevated body-mass index (the weight in kilograms divided by the square of the height in meters) of greater than 35 ...

Jun 14, 2024 · New England Journal of Medicine. Volume 391 • Number 3 • July 18 ... VIC (B.C.V.C), and the Department of Neurology, University of New South Wales South Western Sydney Clinical School ...

Jan 10, 2024 · Most of the patients had either New York Heart Association (NYHA) class II symptoms (72.0%) or class III symptoms (17.2%). The distribution of National Amyloidosis Centre stages 15 was 57% in ...